Amundi X4 Pharmaceuticals, Inc Transaction History

Amundi

$264 Billion
Q3 2024

A detailed history of Amundi transactions in X4 Pharmaceuticals, Inc stock. As of the latest transaction made, Amundi holds 81,305 shares of XFOR stock, worth $49,596. This represents 0.0% of its overall portfolio holdings.

Number of Shares

81,305

Holding current value

$49,596

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2024 Nov 13, 2024	BUY	$0.54 - $0.86 $43,904 - $69,922	81,305 New	81,305 $54,000
Q4 2023 Feb 14, 2024	BUY	$0.61 - $0.99 $49,596 - $80,491	81,305 New	81,305 $68,000

Others Institutions Holding XFOR

# of Institutions

103

Shares Held

99.9M

Call Options Held

213K

Put Options Held

50.6K

Bain Capital Life Sciences Investors, LLC Boston, MA

16.9M
Shares

$10.3 Million
2.03% of portfolio
Nea Management Company, LLC Timonium, MD

15M
Shares

$9.14 Million
0.77% of portfolio
Black Rock Inc. New York, NY

10.7M
Shares

$6.51 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

8.44M
Shares

$5.15 Million
0.0% of portfolio
Orbimed Advisors LLC San Diego, CA

7.13M
Shares

$4.35 Million
0.11% of portfolio

View Full List

About X4 Pharmaceuticals, Inc

Ticker XFOR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,646,096
Market Cap $41.9M
Description
X4 Pharmaceuticals, Inc., a late-stage clinical biopharmaceutical company, focuses on the research, development, and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is mavorixafor, a small molecule inhibitor of the chemokine receptor C-X-C chemokine receptor type 4 (CXCR4), which is in Phase...

More about XFOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account